SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-042382
Filing Date
2019-07-17
Accepted
2019-07-17 16:30:01
Documents
2
Period of Report
2019-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1557
2 POA DOCUMENT poa.txt EX-24.3_865253 3854
  Complete submission text file 0001209191-19-042382.txt   6812
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O EPIZYME, INC., 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Agarwal Shefali (Reporting) CIK: 0001746830 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36076 | Film No.: 19959417